Cost-effectiveness of ranibizumab and bevacizumab for age-related macular degeneration: 2-year findings from the IVAN randomised trial

Helen Dakin, S Wordsworth , Chris Rogers, G abangma, J Raferty , Simon P Harding, Andrew J Lotery, S M Downes, Usha Chakravarthy, Barnaby Reeves

Research output: Contribution to journalArticle (Academic Journal)peer-review

48 Citations (Scopus)
Original languageEnglish
Article numbere005094
JournalBMJ Open
Volume4
DOIs
Publication statusPublished - 29 Jul 2014

Structured keywords

  • BTC (Bristol Trials Centre)
  • Centre for Surgical Research

Cite this